Naltrexone, an opioid antagonist approved in 1994 by the US Food and Drug Administration for alcohol-dependence treatment, can reduce relapse rates among AD patients. Research on naltrexone’s effectiveness on nicotine dependence is less clear, although researchers believe it may be helpful for specific smoker subgroups. A new study has found that naltrexone can help non-AD smokers who drink heavily on a social basis.
Don’t pay for your electricity any longer…
Instead, the power company will pay YOU!
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
0 Responses
Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.